申请人:Clark Richard
公开号:US20090270433A1
公开(公告)日:2009-10-29
A compound represented by the following general formula (1), or a salt thereof has serine protease inhibiting activity, and particularly excellent inhibiting activity against clotting factor VIIa. This compound or a salt thereof is useful as therapeutic and/or prophylactic agents for diseases associated with thrombus formation.
[wherein R
1
represents hydrogen, R
2
represents optionally substituted phenyl, etc., R
3
represents optionally substituted C6-10 aryl, etc.]
下列通式(1)所代表的化合物或其盐具有丝氨酸蛋白酶抑制活性,尤其对凝血因子VIIa有着卓越的抑制活性。该化合物或其盐可作为治疗和/或预防与血栓形成相关的疾病的药物。【其中,R1代表氢,R2代表可选取代的苯基等,R3代表可选取代的C6-10芳基等】。